BPC-157 vs Ipamorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
BPC-157 is a synthetic 15-amino acid peptide derived from gastric juice. It accelerates tissue repair, tendon healing, and gut protection via angiogenesis and growth hormone receptor upregulation. Orally bioavailable and stable in gastric acid. Extensive preclinical evidence acro...
Calculate BPC-157 dose →Ipamorelin is a synthetic 5-amino acid growth hormone releasing peptide (GHRP) that selectively stimulates pituitary GH secretion without raising cortisol, prolactin, or appetite hormones. Acts on ghrelin receptors (GHSR-1a) for clean pulsatile GH release. Phase I/II research sta...
Calculate Ipamorelin dose →| Parameter | BPC-157 | Ipamorelin |
|---|---|---|
| Category | Healing & Recovery | Growth Hormone |
| Research | Extensively Studied | Extensively Studied |
| Half-Life | 4–6 hours | ~2 hours |
| Typical Dose | 200–500 µg | 100–300 µg |
| Frequency | Once or twice daily | 1–3× daily |
| Route | Subcutaneous / Oral | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.